Nuvation Bio nears commercial stage with AnHeart buy March 26, 2024 AutoBot News 0 Nuvation Bio has accelerated its development into a commercial-stage biotech with a deal to acquire AnHeart Therapeutics and its late-stage lung cancer therapy taletrectinib.